Press Releases

BioreclamationIVT Signs Exclusive Agreement To Distribute Cellaria Cell Models And Media For Cancer Research

By Lauren Vagnone | April 13, 2017

Westbury, NY – BioreclamationIVT, a leading provider of biospecimens and related services, has signed a new distribution partnership agreement with Cellaria, LLC. According to the terms of the agreement, BioreclamationIVT will have exclusive market and distribution rights to Cellaria’s novel cancer cell lines and cancer culture media in the United States and Canada and non-exclusive rights to sell the products globally. The agreement expands the availability of Cellaria’s offerings to a broader range of potential customers via an established distribution partner with existing relationships inside the biopharmaceutical industry. …
Read more

BioreclamationIVT Acquires TransCell Science

By Lauren Vagnone | March 9, 2017

Westbury, NY  – BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for phenotypic screening assays.  With its scientific expertise in the areas of cell culture and cell-based assays, clients have looked to TransCell as a partner in developing protocols and conducting studies that provide pertinent data for their research programs.  The output from such studies enables “go” or “no go” decisions with a higher level of confidence at a much earlier time point within the drug discovery process and greatly reduces the chance of downstream failure.

Through prior acquisitions and organic growth, BioreclamationIVT has become the premier supplier of biological specimens to the life sciences industry.  “We have enormous respect for what TransCell Science has accomplished since their founding in 2011,” said Jeff Gatz, BioreclamationIVT CEO.  “Building upon our collective synergies, this transaction positions us to accelerate growth and unleash the full potential of our merged companies.  Together, BioreclamationIVT and TransCell Science will form a complete solution spanning biospecimen acquisition to use of those samples within highly relevant in vitro assays.” …
Read more

ILSBio, LLC merges with BioreclamationIVT

By Lauren Vagnone | July 15, 2015

Westbury, NY – BioreclamationIVT has acquired TransCell Science, a privately held contract research organization (CRO) specializing in the use of primary cells for phenotypic screening assays. With its scientific expertise in the areas of cell culture and cell-based assays, clients have looked to TransCell as a partner in developing protocols and conducting studies that provide pertinent data for their research programs. The output from such studies enables “go” or “no go” decisions with a higher level of confidence at a much earlier time point within the drug discovery process and greatly reduces the chance of downstream failure.

Through prior acquisitions and organic growth, BioreclamationIVT has become the premier supplier of biological specimens to the life sciences industry. “We have enormous respect for what TransCell Science has accomplished since their founding in 2011,” said Jeff Gatz, BioreclamationIVT CEO. “Building upon our collective synergies, this transaction positions us to accelerate growth and unleash the full potential of our merged companies. Together, BioreclamationIVT and TransCell Science will form a complete solution spanning biospecimen acquisition to use of those samples within highly relevant in vitro assays.” …
Read more